Selecta Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
SEL-399 (empty AAV8 capsid with ImmTOR) study on track with topline data expected in the…
SEL-399 (empty AAV8 capsid with ImmTOR) study on track with topline data expected in the…
CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset…
SEL-399 (empty AAV8 capsid with ImmTOR) study on track with topline data expected in the…
Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021 Lead…
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021 Lead…
Total Revenue for Q1 2021 was approximately $0.8 million Balance sheet strengthened significantly with an…
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
Total Revenue for Q1 2021 was approximately $0.8 million Balance sheet strengthened significantly with an…
TORONTO, May 13, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:…
Total Revenue for Q1 2021 was approximately $0.8 million Balance sheet strengthened significantly with an…
TORONTO, May 13, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:…
SAN CARLOS Calif., May 13, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
TORONTO, May 13, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:…
SAN CARLOS Calif., May 13, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
~ FDA Sets Prescription Drug User Fee Act (PDUFA) Target Action Date of January 1,…
Clinical trials underway with next-generation candidates incorporating PN chemistry Clinical data from PN chemistry programs…
NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced…